Rolf Stahel, MD
ETOP IBCSG Partners Foundation · University Hospital Zuerich, Zurich, Switzerland · Trial Co-Chair, University Hospital of Zuerich, Switzerland
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rolf Stahel, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:56 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05522660 · Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung CancerETOP IBCSG Partners Foundation · recruiting · Non-Small Cell Lung Cancer, Melanoma · study chair
- Ph2NCT03133546 · Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790METOP IBCSG Partners Foundation · completed · Non Small Cell Lung Cancer Metastatic · study chair
- Ph3NCT02129699 · Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapyETOP IBCSG Partners Foundation · terminated · Lung Cancer Non-small Cell Stage IV · study chair
- Ph3NCT01652469 · Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.ETOP IBCSG Partners Foundation · completed · Carcinoma, Non-Small-Cell Lung · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.